Cargando…

EGFR-specific CAR-T cells trigger cell lysis in EGFR-positive TNBC

Triple-negative breast cancer (TNBC) is an aggressive cancer subtype for which effective therapies are lacking. Epidermal growth factor receptor (EGFR) is overexpressed in various types of TNBC cells, and several EGFR-specific immunotherapies have been used to treat cancer patients. Chimeric antigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yan, Zhou, Yehui, Huang, Kuo-Hsiang, Li, Ying, Fang, Xujie, An, Li, Wang, Feifei, Chen, Qingfei, Zhang, Yunchao, Shi, Aihua, Yu, Shuang, Zhang, Jingzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6932924/ https://www.ncbi.nlm.nih.gov/pubmed/31804974 http://dx.doi.org/10.18632/aging.102510

Ejemplares similares

Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
por: Liu, Yan, et al.
Publicado: (2020)

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
por: Carroll, Natalie, et al.
Publicado: (2022)

Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells
por: Shin, Miyoung, et al.
Publicado: (2015)

BCAP31 drives TNBC development by modulating ligand-independent EGFR trafficking and spontaneous EGFR phosphorylation
por: Fu, Wenyan, et al.
Publicado: (2019)

EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma
por: Ravanpay, Ali C., et al.
Publicado: (2019)

IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells
por: Merrouche, Yacine, et al.
Publicado: (2016)

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
por: Kim, Seongjae, et al.
Publicado: (2023)

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017)

The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma
por: Dong, Yi-Han, et al.
Publicado: (2018)

Antitumor activity of EGFR-specific CAR T cells against non-small-cell lung cancer cells in vitro and in mice
por: Li, He, et al.
Publicado: (2018)

Electron transfer-triggered imaging of EGFR signaling activity
por: Tan, Jie, et al.
Publicado: (2022)

Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth
por: Yao, Nan, et al.
Publicado: (2020)

Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer‐related pathways in breast cancer
por: Liu, Yan, et al.
Publicado: (2019)

The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs
por: Sun, Li, et al.
Publicado: (2019)

Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC
por: Yu, Min, et al.
Publicado: (2022)

Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report
por: Zhang, Qianyu, et al.
Publicado: (2022)

Identifying EGFR-Expressed Cells and Detecting EGFR Multi-Mutations at Single-Cell Level by Microfluidic Chip
por: Li, Ren, et al.
Publicado: (2017)

Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c‐MYC axis in breast cancer
por: Liu, Yan, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) gene alteration and protein overexpression in Malaysian triple-negative breast cancer (TNBC) cohort
por: Zakaria, Zubaidah, et al.
Publicado: (2019)

Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods
por: Vyshnavi, Hima, et al.
Publicado: (2023)

EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
por: Gu, Weiguang, et al.
Publicado: (2023)

EGFR-TKIs resistance via EGFR-independent signaling pathways
por: Liu, Qian, et al.
Publicado: (2018)

Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas
por: Gong, Yixuan, et al.
Publicado: (2007)

Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression
por: Huang, Zhixin, et al.
Publicado: (2019)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen, Miaomiao, et al.
Publicado: (2018)

CAR-T cells targeting HLA-G as potent therapeutic strategy for EGFR-mutated and overexpressed oral cancer
por: Lin, Yu-Chuan, et al.
Publicado: (2023)

Photothermolysis mediated by gold nanorods modified with EGFR monoclonal antibody induces Hep-2 cells apoptosis in vitro and in vivo
por: Zhang, Shiwen, et al.
Publicado: (2014)

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs
por: Zhu, Yan-juan, et al.
Publicado: (2017)

Highly Efficient Targeting of EGFR-Expressing Tumor Cells with UniCAR T Cells via Target Modules Based on Cetuximab(®)
por: Jureczek, Justyna, et al.
Publicado: (2020)

Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer
por: Gao, Xin, et al.
Publicado: (2020)

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
por: Zhang, Shi-Ling, et al.
Publicado: (2023)

Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance
por: Han, Ruoshuang, et al.
Publicado: (2021)

EGFR Suppression Inhibits the Sphere Formation of MCF7 Cells Overexpressing EGFR
por: Novak, D. D., et al.
Publicado: (2023)

On the mechanisms of lysis triggered by perturbations of bacterial cell wall biosynthesis
por: Kawai, Yoshikazu, et al.
Publicado: (2023)

Optimized selection of three major EGFR-TKIs in advanced EGFR-positive non-small cell lung cancer: a network metaanalysis
por: Zhang, Yaxiong, et al.
Publicado: (2016)

EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo
por: Xia, Lin, et al.
Publicado: (2020)

CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells
por: Deng, Wenjie, et al.
Publicado: (2016)

EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma
por: Schuler, Patrick J, et al.
Publicado: (2011)

Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report
por: Shan, Bin-Bin, et al.
Publicado: (2022)

A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
por: Chen, Xilin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hau87diptbmqbk5vavi8hncujq